Effects of somatostatin analogs octreotide and lanreotide on the proliferation and apoptosis in colon 38 tumor: Interaction with 5-fluorouracil.

Neuroendocrinology Letters

Volumn 21, Issue 2, 2000, Pages 137-142

  Melen Mucha, Gabriela ^a   Winczyk, Katarzyna ^a   Pawlikowski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Colonic cancer; Lanreotide; Octreotide; Proliferation

Indexed keywords

ANGIOPEPTIN; BROXURIDINE; DNA FRAGMENT; FLUOROURACIL; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL NUCLEUS; CELL PROLIFERATION; COLON TUMOR; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; TUMOR VOLUME;

EID: 0034112621     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pawlikowski M, Kunert-Radek J, Stepién H. Somatostatin - an antiproliferative hormone. In: Döhler KD, Pawlikowski M, editors. Progress in Neuropeptide Research. Basel: Birkhauser Verlag; 1989. p. 3-12.
2. Schally AV. Oncological applications of somatostatin analogues. Cancer Res 1988; 48:6977-85.
3. Reubi JC. Octreotide and nonendocrine tumors: basic knowledge and therapeutic potential. In: Lomax P, Scarpignato C, Vesell ES, editors. Progress in Basic and Clinical Pharmacology. Octreotide: from Basic Science to Clinical Medicine. Basel: Karger; 1996. p. 246-69.
4. Dy DY, Whitehead RH, Morris DL. SMS 201 995 inhibits in vitro and in vivo growth of human colon cancer. Cancer Res 1992; 52:917-23.
5. Pawlikowski M, Kunert-Radek J, Winczyk K. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro. Cytobios 1997; 89:183-7.
6. Melen-Mucha G, Winczyk K, Pawlikowski M. Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine Colon 38 cancer. Anticancer Res 1998; 18:3615-9.
7. Romani R, Morris DL. SMS 201.995 (Sandostatin) enhances in-vitro effects of 5-fluorouracil in colorectal cancer. Eur J Surg Oncol 1995; 21:27-32.
8. Pawlikowski M, Winczyk K, Melen-Mucha G. Effect of somatostatin analog octreotide and some other antiproliferative agents on growth of transplantable colonic cancer in mice. Med Sci Monit 1997; 3:465-7.
9. Chen TB, Huzak M, Macura S, Vuk-Pavlovi S. Somatostatin analogue octreotide modulates metabolism and effects of 5-fluorouracil and 5-fluorouridine in human colon cancer spheroids. Cancer Lett 1994; 86:41-51.
10. Smith JP, Croitoru R, Doll D, Thornton C, Perry MC. Effects of octreotide, a long acting Somatostatin analog, on advanced colon cancer. Gastroenterology 1992; 102(suppl 4):A 399.
11. Gratzner HG. Monoclonal antibody to 5-bromo-and 5-iodode-oxyuridine: a new reagent for detection of DNA replication. Science 1982; 218:474-5.
12. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
13. Pritchard DM, Potten CS, Hickman JA. The relationships between p53-dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res 1998; 58:5453-65.
14. Greenberg HS, Chandler WF, Ensminger WD. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/-5-fluorouracil biomodulation for malignant gliomas. Neurology 1994; 44:1715-20.
15. Weckbecker G, Raulf F, Tolcsvai L, Bruns C. Potentiation of the antiproliferative effects of anticancer drugs by octreotide in vitro and in vivo. Digestion 1995; 57(suppl.1):22-8.
16. Inada T, Ichikawa A, Kubota T, Ogata Y, Moossa A, Hoffman RM. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res 1997; 17:1965-72.
17. Yamane N, Makino M, Kaibara N. S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells. Cancer 1999; 85:309-17.
18. Sharma R, Adam E, Schumacher U. The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation. Br J Cancer 1997; 76(8):1011-16.
19. Morgan B, Coy D, Taylor J, Murphy W. The influence of structure on subtype selectivity and efficacy at Somatostatin receptors. J Endocrinol Invest 1997; 20 (suppl to No. 7):5-7.
20. Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human Somatostatin receptor 3. Mol Endocrinol 1996; 10:1688-96.
21. Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59:1391-99.
22. Canman CE, Gilmer TM, Counts SB, Kastan MB. Growth factor modulation of p53 mediated growth arrest versus apoptosis. Genes Develop 1995; 9:600-11.
23. Danesi R, Del Tacca M. Effects of octreotide on angiogenesis. In: Lomax P, Scarpignato C, Vesell ES, editors. Progress in Basic and Clinical Pharmacology. Octreotide: from Basic Science to Clinical Medicine. Basel: Karger; 1996. p. 234-45.